Regulatory assessment of in vitro skin corrosion and irritation data within the European framework: Workshop recommendations

Services & Consultation on Alternative Methods (SeCAM), Agno, Switzerland.
Regulatory Toxicology and Pharmacology (Impact Factor: 2.03). 11/2011; 62(2):393-403. DOI: 10.1016/j.yrtph.2011.10.015
Source: PubMed


Validated in vitro methods for skin corrosion and irritation were adopted by the OECD and by the European Union during the last decade. In the EU, Switzerland and countries adopting the EU legislation, these assays may allow the full replacement of animal testing for identifying and classifying compounds as skin corrosives, skin irritants, and non irritants. In order to develop harmonised recommendations on the use of in vitro data for regulatory assessment purposes within the European framework, a workshop was organized by the Swiss Federal Office of Public Health together with ECVAM and the BfR. It comprised stakeholders from various European countries involved in the process from in vitro testing to the regulatory assessment of in vitro data. Discussions addressed the following questions: (1) the information requirements considered useful for regulatory assessment; (2) the applicability of in vitro skin corrosion data to assign the corrosive subcategories as implemented by the EU Classification, Labelling and Packaging Regulation; (3) the applicability of testing strategies for determining skin corrosion and irritation hazards; and (4) the applicability of the adopted in vitro assays to test mixtures, preparations and dilutions. Overall, a number of agreements and recommendations were achieved in order to clarify and facilitate the assessment and use of in vitro data from regulatory accepted methods, and ultimately help regulators and scientists facing with the new in vitro approaches to evaluate skin irritation and corrosion hazards and risks without animal data.

  • Source
    • "However, they are transitioning to in vitro data from alternative methods using human skin models [19]. For the regulatory use of in vitro data using skin models, the skin models should be validated before test [20,21]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives Effects of nanoparticles including zinc oxide nanoparticles, titanium oxide nanoparticles, and their mixtures on skin corrosion and irritation were investigated by using in vitro 3D human skin models (KeraSkinTM) and the results were compared to those of an in vivo animal test. Methods Skin models were incubated with nanoparticles for a definite time period and cell viability was measured by the 3-(4, 5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide method. Skin corrosion and irritation were identified by the decreased viability based on the pre-determined threshold. Results Cell viability after exposure to nanomaterial was not decreased to the pre-determined threshold level, which was 15% after 60 minutes exposure in corrosion test and 50% after 45 minutes exposure in the irritation test. IL-1α release and histopathological findings support the results of cell viability test. In vivo test using rabbits also showed non-corrosive and non-irritant results. Conclusions The findings provide the evidence that zinc oxide nanoparticles, titanium oxide nanoparticles and their mixture are ‘non corrosive’ and ‘non-irritant’ to the human skin by a globally harmonized classification system. In vivo test using animals can be replaced by an alternative in vitro test.
    Full-text · Article · Jul 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The outermost protective layer of the skin, the stratum corneum, is responsible for skin impermeability toward external medications and potentially harmful chemicals. Stratum corneum is the target for physical and chemical approaches to enhance drug permeation. These approaches are commonly investigated in the field of drug delivery, but the drug absorption enhancement is often linked with local toxicity. In this review we are discussing two emerging technologies for drug and chemical studies in the skin: organotypic cell cultures and non-invasive two-photon microscopic imaging. Even though several cell culture based 'skin equivalents' have been introduced and validated for skin irritation testing, they are usually leaky and inadequately characterized in terms of permeation. Rat epidermal culture model (ROC) has been thoroughly characterized and it shows comparable barrier properties with the human skin thereby being useful in drug permeation and toxicity studies. In vitro and in vivo visualizations of permeants and skin structures are now feasible due to the rapid development of two-photon microscopy that allows improved depth scanning and direct in vivo visualization of the permeating compounds and adverse reactions in the skin structures. In summary, the new tools in percutaneous drug delivery studies will provide new insights to the permeation process and local toxicity. These tools may facilitate development of effective and safe transdermal drug delivery methods.
    Full-text · Article · Mar 2012 · Journal of Controlled Release
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Skin irritation evaluation is an important endpoint for the safety assessment of cosmetic ingredients required by various regulatory authorities for notification and/or import of test substances. The present study was undertaken to investigate possible protocol adaptations of the currently validated in vitro skin irritation test methods based on reconstructed human epidermis (RhE) for the testing of plant extracts and natural botanicals. Due to their specific physico-chemical properties, such as lipophilicity, sticky/buttery-like texture, waxy/creamy foam characteristics, normal washing procedures can lead to an incomplete removal of these materials and/or to mechanical damage to the tissues, resulting in an impaired prediction of the true skin irritation potential of the materials. For this reason different refined washing procedures were evaluated for their ability to ensure appropriate removal of greasy and sticky substances while not altering the normal responses of the validated RhE test method. Amongst the different procedures evaluated, the use of a SDS 0.1% PBS solution to remove the sticky and greasy test material prior to the normal washing procedures was found to be the most suitable adaptation to ensure efficient removal of greasy and sticky in-house controls without affecting the results of the negative control. The predictive capacity of the refined SDS 0.1% washing procedure, was investigated by using twelve oily and viscous compounds having known skin irritation effects supported by raw and/or peer reviewed in vivo data. The normal washing procedure resulted in 8 out of 10 correctly predicted compounds as compared to 9 out of 10 with the refined washing procedures, showing an increase in the predictive ability of the assay. The refined washing procedure allowed to correctly identify all in vivo skin irritant materials showing the same sensitivity as the normal washing procedures, and further increased the specificity of the assay from 5 to 6 correct predictions out of 7 non irritants as compared to the normal washing procedures. In addition, when exposed to non-irritant oily and viscous materials, tissues rinsed with 0.1% SDS generally showed increased viabilities accompanied by decreased variabilities as compared to the normal washing procedures. Similar results were obtained when testing typical in-house natural botanical ingredients. In conclusion, the use of a refined washing procedure making use of SDS 0.1% in PBS was found a suitable procedure to ensure efficient removal of greasy and sticky materials, leading to an increased predictive capacity and decreased variability of the tissue responses while maintaining its sensitivity and not affecting untreated tissues morphology and viability.
    Full-text · Article · Aug 2012 · Toxicology in Vitro
Show more